Anika Therapeutics Management
Management criteria checks 3/4
Anika Therapeutics' CEO is Cheryl Blanchard, appointed in Feb 2020, has a tenure of 4.33 years. total yearly compensation is $4.46M, comprised of 16.3% salary and 83.7% bonuses, including company stock and options. directly owns 1.1% of the company’s shares, worth $4.19M. The average tenure of the management team and the board of directors is 2.8 years and 4.3 years respectively.
Key information
Cheryl Blanchard
Chief executive officer
US$4.5m
Total compensation
| CEO salary percentage | 16.3% |
| CEO tenure | 4.3yrs |
| CEO ownership | 1.1% |
| Management average tenure | 2.8yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Is There An Opportunity With Anika Therapeutics, Inc.'s (NASDAQ:ANIK) 44% Undervaluation?
Jan 30
Companies Like Anika Therapeutics (NASDAQ:ANIK) Can Afford To Invest In Growth
Aug 03Anika Therapeutics: New Share Price Low May Imply New Upside Opportunity
Mar 11Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 48%?
Jun 25Anika Therapeutics (ANIK) Presents At UBS Global Healthcare Virtual Conference - Slideshow
May 28Anika Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 07How Much Are Anika Therapeutics, Inc. (NASDAQ:ANIK) Insiders Taking Off The Table?
Mar 16Anika Therapeutics (NASDAQ:ANIK) Seems To Use Debt Quite Sensibly
Feb 09An Intrinsic Calculation For Anika Therapeutics, Inc. (NASDAQ:ANIK) Suggests It's 32% Undervalued
Jan 13If You Had Bought Anika Therapeutics' (NASDAQ:ANIK) Shares A Year Ago You Would Be Down 21%
Dec 18
Anika Therapeutics, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 06CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$77m |
| Dec 31 2023 | US$4m | US$726k | -US$83m |
| Sep 30 2023 | n/a | n/a | -US$25m |
| Jun 30 2023 | n/a | n/a | -US$22m |
| Mar 31 2023 | n/a | n/a | -US$22m |
| Dec 31 2022 | US$6m | US$695k | -US$15m |
| Sep 30 2022 | n/a | n/a | -US$16m |
| Jun 30 2022 | n/a | n/a | -US$11m |
| Mar 31 2022 | n/a | n/a | -US$2m |
| Dec 31 2021 | US$4m | US$668k | US$4m |
| Sep 30 2021 | n/a | n/a | -US$6m |
| Jun 30 2021 | n/a | n/a | -US$13m |
| Mar 31 2021 | n/a | n/a | -US$27m |
| Dec 31 2020 | US$10m | US$548k | -US$24m |
| Sep 30 2020 | n/a | n/a | -US$4m |
| Jun 30 2020 | n/a | n/a | US$11m |
| Mar 31 2020 | n/a | n/a | US$28m |
| Dec 31 2019 | US$187k | n/a | US$27m |
| Sep 30 2019 | n/a | n/a | US$31m |
| Jun 30 2019 | n/a | n/a | US$29m |
| Mar 31 2019 | n/a | n/a | US$30m |
| Dec 31 2018 | US$167k | n/a | US$19m |
Compensation vs Market: Cheryl's total compensation ($USD4.46M) is above average for companies of similar size in the US market ($USD2.46M).
Compensation vs Earnings: Cheryl's compensation has been consistent with company performance over the past year.
CEO
Cheryl Blanchard (60 yo)
4.3yrs
Tenure
US$4,459,800
Compensation
Dr. Cheryl Renee Blanchard, Ph. D. is Director of Elute, Inc. from May 2013. She serves as the President & Chief Executive Officer of Anika Therapeutics, Inc. since April 26, 2020. She serves as Director o...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.3yrs | US$4.46m | 1.1% $ 4.2m | |
| Executive Officer | no data | US$1.65m | 0.32% $ 1.2m | |
| Senior VP & COO | 2.8yrs | US$1.01m | 0.075% $ 284.3k | |
| Executive VP | 4.3yrs | US$1.55m | 0.22% $ 846.3k | |
| VP & Chief Accounting Officer | no data | no data | no data | |
| Executive Director of Investor Relations & Corporate Communications | no data | no data | no data | |
| Senior Vice President of International Sales & Marketing | 4.1yrs | no data | no data | |
| Vice President of Commercial & Corporate Development | 2.4yrs | no data | no data | |
| Vice President of Human Resources | 2.3yrs | no data | no data |
2.8yrs
Average Tenure
55yo
Average Age
Experienced Management: ANIK's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.8yrs | US$4.46m | 1.1% $ 4.2m | |
| Director | less than a year | no data | no data | |
| Independent Chair of the Board | 4.8yrs | US$249.81k | 0.16% $ 601.1k | |
| Independent Director | 5.7yrs | US$248.98k | 0.16% $ 609.9k | |
| Independent Director | 2.7yrs | US$242.48k | 0.090% $ 343.9k | |
| Independent Director | 9.3yrs | US$237.48k | 0.16% $ 611.1k | |
| Director | less than a year | no data | no data | |
| Independent Director | 1.2yrs | US$571.00k | 0.045% $ 169.4k | |
| Independent Director | 13.4yrs | US$267.48k | 0.17% $ 643.2k | |
| Independent Director | 3.8yrs | US$248.98k | 0.14% $ 549.8k |
4.3yrs
Average Tenure
62yo
Average Age
Experienced Board: ANIK's board of directors are considered experienced (4.3 years average tenure).